Abstract

In flow photochemical addition of propellane to diacetyl allowed construction of the bicyclo[1.1.1]pentane (BCP) core in a 1 kg scale within 1 day. Haloform reaction of the formed diketone in batch afforded bicyclo[1.1.1]pentane-1,3-dicarboxylic acid in a multigram amount. Representative gram scale transformations of the diacid were also performed to obtain various BCP-containing building blocks—alcohols, acids, amines, trifluoroborates, amino acids, etc.—for medicinal chemistry.
Introduction
Benzene is the most popular ring in bioactive compounds.1 In particular, the structure of more than 500 drugs comprises the motif of benzene.2 However, bioactive compounds with several phenyl rings often have low solubility in water3 and high toxicity due to rapid oxidation in vivo into quinones.4 On the other hand, because of the recently emerged concept Escape from Flatland,5 today medicinal chemists often replace benzene rings in bioactive compounds with saturated bioisosteres. Apart from improving physicochemical properties—better solubility, lower lipophilicity, and higher metabolic stability—this tactic is also often used to come out of the patented chemical space.6 In particular, in 2012, Stepan and co-workers substituted the phenyl fragment in a γ-secretase inhibitor with the bicyclo[1.1.1]pentyl (BCP) skeleton.7 The obtained analogue showed higher activity, better solubility, and improved metabolic stability. Since then, bicyclo[1.1.1]pentyl-containing derivatives have been playing an important role in medicinal chemistry.8 They have already been mentioned in more than 200 patents (Figure 1).
Figure 1.
Bioactive derivatives of bicyclo[1.1.1]pentane (BCP).
Indeed, an increasing demand from pharmaceutical institutions initiated many academic groups to work on elaboration of novel synthetic approaches to substituted bicyclo[1.1.1]pentanes and their analogues.9−11
Despite the huge development in recent years on the synthesis of bicyclo[1.1.1]pentanes, however, still the most popular approach to them relies on the stepwise modifications of carboxylic groups in diacid 1 (Figure 1).11b In recent years, we received a lot of requests from pharmaceutical companies on various BCP-containing building blocks. Therefore, we needed a practical method to rapidly access multigram quantities of diacid 1.
The first synthesis of diacid 1 was described in 1982 by Applequist.12 The authors converted cyclobutanone 2 into the substituted bicyclo[1.1.0]butane 3 (Scheme 1).13 From that intermediate, diacid 1 was synthesized in five steps in a 400 mg amount. In 1988, Michl developed a practical approach to access diacid 1 (Scheme 1).14,15 The authors performed the photochemical reaction between propellane (4) and diacetyl (5) to produce diketone 6 in 58% yield (2 steps from dibromide 7). The synthesis was performed in batch, and 26 g of the product was obtained in a single run. The photochemical step was performed with a medium-pressure Hanovia mercury lamp in a Pyrex vessel. Haloform reaction of 6 gave the needed diacid 1 in a 25 g scale. In 2014, Booker-Milburn performed a reaction between propellane (4) and diacetyl (5) in flow to obtain 52 g of product 6 (Scheme 1).16 Irradiation was again performed with a medium-pressure Hanovia mercury lamp in Pyrex glassware.
Scheme 1. Approaches to Bicyclo[1.1.1]pentane-1,3-dicarboxylic Acid (1).
Recently, Baumann also developed an elegant photochemical addition of oxalic acid derivatives to propellane in flow using a medium-pressure mercury lamp with filters.17,18
In our first attempts, we repeated the protocol of Kaszynski and Michl which allowed preparing diacid 1 in gram quantities.14,15 However, the need to perform irradiation with (a) a Hanovia mercury lamp (b) in Pyrex glassware prevented further scale-up of this method. Herein, therefore would like to disclose our results and unexpected observations on the rapid practical synthesis of diacid 1. Our protocol employs common LED (365 nm) irradiation with no need to use Pyrex glassware. Because it is still the most popular precursor to BCP derivatives (Figure 1), we believe that these results will be interesting to many organic chemists and medicinal chemists in both industrial and academic institutions.
Results and Discussion
Synthesis and Storage of Propellane (4)
Propellane 4 was first reported in 1982 by Wiberg.19 In 1985, Szeimies developed an alternative synthesis of 4 from dibromide 7,20 and in 1988, Michl optimized it.14 In 1998, Mondanaro and Dailey further optimized the protocol.21
For the synthesis of propellane, we used the procedure of Mondanaro and Dailey.21 Previous reports suggested direct use of propellane after the preparation, because of its extensive polymerization under contact with air.22 We found that the solution of propellane (4) in diethyl ether can be stored at −40 °C for several weeks. Titration with thiophenol revealed that, after 1 month in a fridge, the concentration of 4 in a solution dropped from 0.75 to 0.60 N. Scheme 2 shows a photo of six 1 L bottles with a solution of propellane that we routinely store in a fridge. It is very convenient not to prepare propellane every time, but to keep its stock solution and use when needed. Indeed, the solution in the bottle must be kept under an argon atmosphere.
Scheme 2. Synthesis of Propellane (4).

Photo: six 1 L bottles with a solution of propellane in diethyl ether stored in a fridge at −40 °C.
Multigram Photochemical Preparation of Diketone 6
Initially, we performed photochemical reactions between propellane (4) and diacetyl (5) in batch following the protocol of Michl.14 However, the need to use (a) the broad wavelength mercury lamp and (b) Pyrex glassware somewhat complicated the practical aspects of the procedure. Out of curiosity,23 we tried other standard wavelengths—420 and 365 nm—that are compatible with standard chemical glassware and do not require Pyrex vessels. Under irradiation with 420 nm (blue LED), the reaction did not proceed. However, irradiation with 365 nm led to smooth formation of product 6 at room temperature. Performing the reaction in batch, we could easily synthesize 10 g of diketone 6 (Scheme 3). The reaction was performed in a standard chemical glass flask.
Scheme 3. Photochemical Synthesis of Diketone 6 in Batch.

Irradiation is performed at 365 nm in a standard chemical glass flask.
Having an optimized batch procedure in hand, we attempted next the photochemical reaction in flow. The irradiation was performed at 365 nm.24 A solution of reagents in diethyl ether was pumped via a fluorinated ethylene propylene pipe (0.5 cm inner diameter) through a photoelement.25 After some optimization, we found that the transformation was complete with a 30 mL/min flow rate (4:5 = 1:1; conc. = 0.7 M, Scheme 4). We used 80% of the nominal LED luminescence power (total diode power: 670 W). Interestingly, after the photoreaction, the original deep yellow color of diacetyl (5) became almost white, indicating disappearance of the starting material (Scheme 4: left and right). Using that in flow protocol, we could easily pump 9 L of the reaction mixture through a photoelement and produce ca. 1 kg of diketone 6 within 6 h.
Scheme 4. Photochemical Synthesis of Diketone 6in Flow.

Irradiation is performed at 365 nm in a coil.
Multigram Synthesis of Diacid 1
Multigram synthesis of diacid 1 from ketone 6 was performed following the protocol of Michl14 with a slight modification. Previously, authors purified diketone 6 and then performed the haloform reaction. We found, however, that a higher yield of diacid 1 could be obtained by performing the reaction with crude 6 (obtained by evaporation of the reaction mixture after irradiation). In fact, performing the reaction in a 6 L flask, we could start from ca. 250 g of crude 6 and synthesize 115–133 g of diacid 1 in a single run depending on the batch. Repeating the synthesis four times in total allowed us to synthesize ca. 500 g of diacid 1 (Scheme 5).
Scheme 5. Multigram Scale Synthesis of Diacid 1 in Batch.

Multigram Synthesis of BCP-Containing Building Blocks
As it was mentioned earlier, most of the medchem-related building blocks are still being produced from diacid 1. Having synthesized a significant amount of diacid 1, we would also like to present here its representative multigram functionalizations that were performed before on a smaller scale. Treatment of 1 with SelectFluor (1.2 equiv) in the presence of a catalytic amount of AgNO3 gave fluorine-substituted acid 8(26) in a 54 g scale (Scheme 6), a key intermediate in the synthesis of a 19F NMR label for solid state peptide studies.10a Activation of the carboxylic group in 8 with ClCO2Me and reduction with sodium borohydride gave interesting alcohol 9 in a 10 g amount. Curtius rearrangement of acid 8, followed by acidic N-Boc deprotection, afforded fluoro-substitued amine 10 in a 13 g amount. Esterification of diacid 1 with methanol and monohydrolysis gave valuable linker 11(14) in a 163 g scale. Curtius rearrangement of 11, followed by alkali hydrolysis of the ester group, gave N-Boc amino acid 12 in 40 g quantities. It is worth noting that amino acid 12 was previously used by Pätzel as a mimetic of γ-aminobutyric acid (GABA) in peptides.27 Finally, acylation of N-hydroxyphthalimide with 11, followed by light-mediated decarboxylative borylation with B2Cat2, addition of pinacol, and subsequent treatment with potassium fluoride, gave valuable organotrifluoroborate 13 in a 20 g amount. The compound was first synthesized by Aggarwal,28 and recently, VanHeyst, Qi, and co-workers from Merck used it for practical photoredox cross-couplings of heterocycles.29
Scheme 6. Multigram Scale Synthesis of BCP-Containing Building Blocks 8–13 from Diacid 1.
In addition, we wanted also to disclose here the synthesis of hydroxy acid 14, the compound that, in the unprotected form, was unknown before. There were several attempts before to access the needed core. In 1982, Applequist and colleagues tried hydrolysis of compound 15 in the presence of silver nitrate (Scheme 7).12 However, only ring-opened alkene 16 was isolated in 34% yield, while formation of alcohol 17 was not observed. Recently, Baran and co-workers developed an electrochemical synthesis of hindered ethers and alcohols from carboxylic acids.30 Being involved in this project, we also tried to expand this methodology onto acid 11. For that, a mixture of acid 11 and water in acetone was electrolyzed under a constant current of 10 mA during 3 h (Scheme 7). Unfortunately, formation of the desired product was not observed. Under prolonged electrolysis, only slow decomposition of the starting material took place. Finally, we undertook the synthesis of compound 14 from diacid 1 (Scheme 7). Alkylation of the latter with an excess of benzyl bromide smoothly gave diester 18. Selective alkali monohydrolysis afforded acid 19. Acylation of N-hydroxyphthalimide (via 20), followed by light-mediated decarboxylative borylation with B2Cat2 and addition of pinacol, gave organoboron derivative 21. Reaction with potassium fluoride provided trifluoroborate 22. The key oxidation with hydrogen peroxide formed alcohol 23 in 35% yield. Finally, cleavage of the O–Bn bond by hydrogenation on Pd/C in methanol gave the desired molecule 14 in a 1 g amount. Compound 14 can be viewed as the saturated bioisostere of popular 4-hydroxybenzoic acid (24). Moreover, similar bioisosteric replacement of phenols was recently validated by Adsool and colleagues.31
Scheme 7. Synthesis of BCP-Containing Hydroxy Acid 14.
Conclusion
Most of the medchem-relevant BCP-containing derivatives are obtained today from bicyclo[1.1.1]pentane-1,3-dicarboxylic acid (1) (Figure 1). In this work, we developed its practical synthesis on a multigram scale. The key step was in flow photochemical reaction between propellane (4) and diacetyl (5) under irradiation with 365 nm in flow. Importantly, the procedure was mercury lamp-free and quartz vessels-free. The developed protocol allowed for the rapid production of ca. 1 kg of diketone 6 during 6 h. The target diacid 1 was subsequently synthesized in a 500 g scale by haloform reaction of the diketone in batch. Several representative multigram functionalizations of diacid 1 into medchem-relevant BCP building blocks were also demonstrated (Schemes 6 and 7). We believe that, with the robust practical protocol described here, medicinal chemists worldwide in both industry and academia could easily now synthesize and use BCP molecules routinely.
Experimental Section
General Considerations
All chemicals were provided by Enamine Ltd. (www.enamine.net). All solvents were treated according to standard methods. All reactions were monitored by thin-layer chromatography (TLC) and were visualized using UV light. Product purification was performed using silica gel column chromatography. TLC characterization was performed with precoated silica gel GF254 (0.2 mm), while column chromatography characterization was performed with silica gel (100–200 mesh). 1H NMR spectra were recorded at 400, 500, or 600 MHz (Varian); 19F NMR spectra were recorded at 376 MHz (Varian); and 13C NMR spectra were recorded at 100, 126, or 151 MHz (Varian). 1H NMR chemical shifts are calibrated using residual undeuterated solvents CHCl3 (δ = 7.26 ppm) or DMSO (δ = 2.50 ppm). 13C NMR chemical shifts for 13C NMR are reported relative to the central CHCl3 (δ = 77.16 ppm) or DMSO (δ = 39.52 ppm). 19F NMR chemical shifts are calibrated using CFCl3 as an internal standard. Coupling constants are given in Hz. High-resolution mass spectra (HRMS) were recorded on an Agilent LC/MSD TOF mass spectrometer by electrospray ionization time-of-flight reflectron experiments.
Tricyclo[1.1.1]pentane (Propellane) (4)
A dry three-neck round-bottom flask (6 L) equipped with an overhead stirrer was charged with 1,1-bis(chloromethyl)-2,2-dibromocyclopropane (7) (800.0 g, 2.7 mol, 1.0 equiv) in Et2O (2 L). The mixture was cooled to −78 °C, and MeLi (3 M, 2 L, 6.0 mol, 2.2 equiv) was added dropwise at the same temperature under argon. The mixture was stirred for 30 min at −75 °C, then warmed to 0 °C, and stirred for 1.5 h. The mixture was distilled to a 5 L flask and stored under argon. The mixture was titrated and transferred into 800 mL bottles for storage. Yield: 3.75 L, 0.1 M of 4, 78%. Titration: propellane was titrated with thiophenol. A degassed with argon solution of thiophenol (3.00 g) in Et2O was added to a solution of 4 (10 mL). The mixture was stirred for 15 min, concentrated, and subjected to 1H NMR. The ratio of the obtained PhS-BCP-H and remaining PhSH was calculated based on the proton of the tertiary carbon in propellane at 2.72 ppm (s, 1H) and the proton in PhSH at 3.44 ppm (s, 1H).
1,1′-(Bicyclo[1.1.1]pentane-1,3-diyl)bis(ethan-1-one) (6)
To a solution of 4 (0.7 M, 8 L, 5.6 mol, 1.0 equiv) was added a degassed with argon solution of (MeCO2)2 (482.0 g, 5.6 mol, 1.0 equiv) in Et2O (500 mL). The reaction mixture (9 L) was passed through a photoreactor during 6 h with a flow rate of ca. 30 mL/min. The volume of the illuminated area is 160 mL, and that of the nonilluminated area is 50 mL. The wavelength is 365 nm, and the LED luminescence power is 80% of the nominal (total diode power: 670 W). The mixture was concentrated under reduced pressure. Yield: 821.2 g, 5.4 mol, 94%. This product was used in the next step without additional purification. An analytically pure sample can be obtained by crystallization of the compound from pentane:diethyl ether = 2:1. Mp = 69–70 °C. 1H NMR (400 MHz, CDCl3) δ 2.19 (s, 3H), 2.09 (s, 3H) ppm. 13C{1H} NMR (126 MHz, CDCl3) δ 205.8, 51.9, 43.3, 26.2 ppm. HRMS (ESI-TOF) m/z: [M + H]+ calcd for C9H13O2 153.0916; found 153.0910.
Bicyclo[1.1.1]pentane-1,3-dicarboxylic Acid (1)
A solution of NaOH (1 kg, 24.6 mol, 15.0 equiv) in water (3.5 L) was cooled to 20 °C, and Br2 (2 kg, 12.3 mol, 7.5 equiv) was added to the solution dropwise. The mixture was stirred for 3 h, then cooled to 0 °C, and a solution of ketone 6 (250.0 g, 1.64 mol, 1.0 equiv) in dioxane (1 L) was added dropwise. The mixture was stirred overnight and extracted with CH2Cl2 (3 × 3 L). An aqueous solution was acidified and extracted with EtOAc (3 × 3 L). The organic layers were concentrated under reduced pressure. The residue was mashed in hexane (1 L), then in CH2Cl2 (1 L), and a white precipitate was filtered off. The aqueous layer was also concentrated and additionally extracted with EtOAc (2 × 1 L). Yield: 115.5–133.1 g, 0.74–0.85 mol, 45–51% depending on a batch. After four runs, ca. 500 g of the diacid was obtained. Mp = 169–170 °C. 1H NMR (400 MHz, DMSO-d6) δ 12.50 (br s, 2H), 2.14 (s, 6H) ppm. 13C{1H} NMR (126 MHz, DMSO-d6) δ 170.6, 51.8, 37.2 ppm. HRMS (ESI-TOF) m/z: [M + H]+ calcd for C7H9O4 157.0501; found 157.0508.
3-Fluorobicyclo[1.1.1]pentane-1-carboxylic Acid (8)
Compound 1 (155.0 g, 0.99 mol, 1.0 equiv) and AgNO3 (39.0 g, 0.23 mol, 0.2 equiv) were dissolved in distilled water (3 L). The mixture was degassed with argon (5 times), and Selectfluor (416.0 g, 1.18 mol, 1.2 equiv) was added. The mixture was degassed with argon (2 times) and heated at 70 °C in an oil bath with a thermocouple for 24 h. The solution was cooled to room temperature and extracted with MeOtBu (3 × 1 L). The organic layer was concentrated under reduced pressure. The solid residue was recrystallized from a mixture of MeOtBu:pentane = 1:9 to give the title product as a yellow solid. Mp = 95–97 °C. Yield: 54.0 g, 0.41 mol, 42%. 1H NMR (400 MHz, CDCl3) δ 11.05 (br s, 1H), 2.39 (s, 6H) ppm. 13C{1H} NMR (126 MHz, CDCl3) δ 175.5 (d, J = 37 Hz), 74.8 (d, J = 329 Hz), 55.7 (d, J = 22 Hz), 28.2 (d, J = 48 Hz) ppm. 19F{1H} NMR (376 MHz, CDCl3) δ −150.3 (s) ppm. HRMS (ESI-TOF) m/z: [M + H]+ calcd for C6H7FO2 130.0430; found 130.0432.
(3-Fluorobicyclo[1.1.1]pentan-1-yl)methanol (9)
Compound 8 (13.0 g, 0.100 mol, 1.0 equiv) was dissolved in THF (200 mL). The solution was degassed with argon and cooled to 0 °C, and BH3·Me2S (11.7 g, 0.15 mol, 1.5 equiv) was added dropwise. The mixture was stirred at room temperature overnight, then cooled to 0 °C, and dry MeOH (100 mL) was added dropwise. The mixture was stirred for 5 h at room temperature and concentrated under reduced pressure. The residue was distilled at 1 mmHg. Yield: 10.1 g, 0.087 mol, 86%, colorless oil. 1H NMR (400 MHz, CDCl3) δ 3.82 (s, 2H), 1.99 (d, J = 2.5 Hz, 6H), 1.81 (s, 1H) ppm. 13C{1H} NMR (126 MHz, CDCl3) δ 75.9 (d, J = 329 Hz), 60.8 (d, J = 27 Hz), 52.4 (d, J = 21 Hz), 29.3 (d, J = 41 Hz) ppm. 19F{1H} NMR (376 MHz, CDCl3) δ −145.7 (s) ppm. HRMS (ESI-TOF) m/z: [M + H]+ calcd for C6H10FO 117.0716; found 117.0712.
3-Fluorobicyclo[1.1.1]pentan-1-amine Hydrochloride (10)
Compound 8 (16.0 g, 0.125 mol, 1.0 equiv) was dissolved in tBuOH (500 mL). Et3N (15.0 g, 0.150 mol, 1.2 equiv) and (PhO)2P(O)N3 (38.0 g, 0.137 mol, 1.1 equiv) were added to the solution. The mixture was heated at 85 °C in an oil bath with a thermocouple for 24 h, cooled to room temperature, and concentrated under reduced pressure. The residue was dissolved in EtOAc (500 mL) and washed with a sat. solution of NaHCO3 (200 mL), water (250 mL), and brine (250 mL). The organic layer was dried over Na2SO4, filtered, and concentrated. The crude product was purified by column chromatography (gradient, hexane:MeOtBu = 1:9 to 1:1). Yield: 21.2 g, 0.105 mol, 83%. 1H NMR (500 MHz, CDCl3) δ 4.95 (br s, 1H), 2.30 (s, 6H), 1.42 (s, 9H) ppm. 13C{1H} NMR (126 MHz, CDCl3) δ 154.9, 80.2, 76.8 (d, J = 316 Hz), 55.3 (d, J = 20 Hz), 39.9 (d, J = 72 Hz), 28.5 ppm. 19F{1H} NMR (376 MHz, CDCl3) δ −169.6 (s) ppm. The total amount of the product was dissolved in 5 M HCl in dioxane (500 mL) and stirred at room temperature overnight. The mixture was concentrated under reduced pressure. The solid residue was washed with MeOtBu (1 L) and dried (under reduced pressure, 1 mmHg at 50 °C in a heating mantle). Yield: 13.5 g, 0.098 mol, 95%, white solid. 1H NMR (500 MHz, DMSO-d6) δ 9.43 (s, 3H), 2.33 (s, 6H). ppm. 13C{1H} NMR (126 MHz, DMSO-d6) δ 75.6 (d, J = 321 Hz), 54.3 (d, J = 21 Hz), 37.6 (d, J = 72 Hz) ppm. 19F{1H} NMR (376 MHz, DMSO-d6) δ −166.6 (s) ppm. HRMS (ESI-TOF) m/z: [M + H]+ calcd for C5H9FN 102.0719; found 102.0715.
3-(Methoxycarbonyl)bicyclo[1.1.1]pentane-1-carboxylic Acid (11)
Compound 1 (200.0 g, 1.28 mol, 1.0 equiv) was dissolved in MeOH (3 L), and SOCl2 (457.0 g, 3.84 mol, 3.0 equiv) was added dropwise at 20–40 °C. The mixture was stirred at room temperature overnight and concentrated under reduced pressure. The mixture was dissolved in a mixture of hexane:MeOtBu = 1:1 (1 L), filtered through SiO2 (∼500 g), and concentrated. Yield: 196.1 g, 1.06 mol, 83%, white solid, mp 90–91 °C. 1H NMR (400 MHz, CDCl3) δ 3.68 (s, 3H), 2.31 (s, 3H) ppm. 13C{1H} NMR (151 MHz, CDCl3) δ 170.3, 54.3, 51.9, 45.8, 28.5 ppm. HRMS (ESI-TOF) m/z: [M + H]+ calcd for C9H13O4 185.0814; found 185.0810. The product (196.1 g, 1.06 mol, 1.0 equiv) was dissolved in THF (2 L), and LiOH·H2O (40.0 g, 0.95 mol, 0.9 equiv) was added to the mixture. The mixture was heated in an oil bath with a thermocouple at 50 °C for 72 h, then cooled to room temperature, and concentrated under reduced pressure. The residue was dissolved in water (1 L) and extracted with MeOtBu (3 × 500 mL). The aqueous layer was acidified with HCl to pH ∼3–4. The precipitate was filtered off and dried at 1 mmHg over P2O5. Yield: 163.3 g, 0.96 mol, 90%. Yellow solid. Mp = 126–127 °C. 1H NMR (400 MHz, CDCl3) δ 11.15 (br s, 1H), 3.69 (s, 3H), 2.34 (s, 6H) ppm. 13C{1H} NMR (151 MHz, CDCl3) δ 175.2, 169.8, 52.9, 52.1, 37.7, 37.6 ppm. HRMS (ESI-TOF) m/z: [M + H]+ calcd for C8H11O4 171.0657; found 171.0655.
3-((tert-Butoxycarbonyl)amino)bicyclo[1.1.1]pentane-1-carboxylic Acid (12)
Compound 11 (40.0 g, 0.23 mol, 1.0 equiv) was dissolved in tBuOH (1 L). Et3N (28.0 g, 0.27 mol, 1.2 equiv) and (PhO)2P(O)N3 (70.0 g, 0.25 mol, 1.1 equiv) were added to the solution. The mixture was heated in an oil bath with a thermocouple at 85 °C for 24 h, then cooled to room temperature, and concentrated under reduced pressure. The residue was dissolved in EtOAc (1 L) and washed with a saturated aqueous solution of NaHCO3 (2 × 400 mL), water (500 mL), and brine (500 mL). The organic layer was dried over Na2SO4, filtered, and concentrated. The crude product was purified by column chromatography (gradient, hexane:MeOtBu = 1:9 to 1:1). Yield: 44.0 g, 0.19 mol, 80%, white solid. Mp = 138–139 °C. 1H NMR (400 MHz, CDCl3) δ 5.00 (br s, 1H), 3.67 (s, 3H), 2.27 (s, 6H), 1.43 (s, 9H) ppm. 13C{1H} NMR (151 MHz, CDCl3) δ 169.8, 53.0, 51.9, 37.7 ppm. HRMS (ESI-TOF) m/z: [M + H]+ calcd for C12H20NO4 242.1392; found 242.1399. The product was dissolved in a mixture of THF and H2O (7:3, 500 mL), and LiOH·H2O (11.5 g, 0.28 mol, 1.5 equiv) was added to the mixture. The mixture was stirred overnight at room temperature and then concentrated under reduced pressure. The residue was dissolved in distilled water (500 mL) and extracted with MeOtBu (3 × 500 mL). The aqueous layer was acidified with citric acid to pH ∼ 6 and extracted with EtOAc (3 × 300 mL). The combined organic layers were dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude product was recrystallized from a mixture of hexane:EtOAc = 7:3 (the product was boiled in hexane and EtOAc was added in portions). Yield: 40.0 g, 0.176 mol, 95%, white solid. Mp = 176–177 °C. 1H NMR (400 MHz, DMSO-d6) δ 12.37 (br s, 1H), 7.58 (br s, 1H), 2.08 (s, 6H), 1.37 (s, 9H) ppm. 13C{1H} NMR (126 MHz, DMSO-d6) δ 170.9, 154.5, 53.4, 45.1, 28.2 ppm. LCMS (M – H)−: 226. HRMS (ESI-TOF) m/z: [M + H]+ calcd for C11H18NO4 228.1236; found 228.1239.
Potassium Trifluoro[3-(methoxycarbonyl)bicyclo[1.1.1]pentan-1-yl]boranuide (13)
Compound 11 (50.0 g, 0.29 mol, 1.0 equiv) was dissolved in CH2Cl2 (1 L), and N-hydroxyphthalimide (48.0 g, 0.29 mol, 1 equiv), 4-(dimethylamino)pyridine, and DMAP (3.51 g, 0.029 mol, 0.1 equiv) were added. N,N′-diisopropylcarbodiimide, DIC (44.0 g, 0.35 mol, 1.2 equiv), was added to the mixture dropwise at room temperature. The mixture was stirred at room temperature overnight. The mixture was filtered, and a filtrate was concentrated under reduced pressure. 1H NMR (500 MHz CDCl3) δ 7.86 (dt, J = 7.0, 3.5 Hz, 2H), 7.77 (dd, J = 5.6, 3.1 Hz, 2H), 3.70 (s, 3H), 2.53 (s, 6H) ppm. The crude product (100.1 g, 0.29 mol, 1.0 equiv) and 2,2′-bis(1,3,2-benzodioxaborole), B2Cat2 (83.0 g, 0.35 mol, 1.2 equiv), were dissolved in DMA (3 L). The mixture was degassed with argon (5 times) then irradiated in flow. Irradiation: blue LED: 450 nm, spiral volume: 320 mL, flow rate: 10 mL/min, radiation intensity: 50% of nominal (total diode power: 850 W), residence time in the spiral: 32 min, temperature on the cooler: −20 °C, the temperature of the reaction mixture at the outlet: 16 °C. After completion of the reaction, Et3N (88.0 g, 125 mL, 0.87 mol, 3.0 equiv) and pinacol (51.0 g, 0.435 mol, 1.5 equiv) were added to the reaction mixture, and it was stirred overnight at room temperature. The mixture was extracted with a mixture hexane:EtOAc = 9:1 (5 × 500 mL) and concentrated. The residue was extracted with hexane (3 × 500 mL). The combined organic layers were washed with water (2 × 300 mL) and brine (300 mL), dried over Na2SO4, filtered, and concentrated under reduced pressure. The final product had ca. 85% purity according to 1H NMR. Yield 38.2 g, 0.12 mol, 45%. 1H NMR (500 MHz, CDCl3) δ 3.64 (s, 3H), 2.14 (s, 6H), 1.24 (s, 12H) ppm. The obtained crude product (38.2 g, 0.12 mol, 1.0 equiv) was dissolved in a mixture of MeOH:H2O = 8:2 (400 mL), and KF·HF (25.0 g, 0.32 mol, 2.5 equiv) was added. The mixture was stirred at room temperature overnight and then concentrated. The final product was dried at 1 mmHg over P2O5 during 24 h. The product was mashed in MeOtBu (3 L), and the precipitate was extracted with acetone using a Soxhlet extractor for 48 h. Yield: 20.0 g, 67%, white solid. Mp = 264–265 °C. 1H NMR (400 MHz, DMSO-d6) δ 3.51 (s, 3H), 1.59 (s, 6H) ppm. 13C{1H} NMR (126 MHz, DMSO-d6) δ 170.5, 50.7, 50.4 ppm. 19F{1H} NMR (376 MHz, DMSO-d6) δ −143.5 (s) ppm. Anal. Calcd for C7H9BF3KO2: C, 36.23; H, 3.91. Found: C, 36.10; H, 4.05.
Dibenzyl Bicyclo[1.1.1]pentane-1,3-dicarboxylate (18)
To a solution of compound 11 (50.00 g, 0.32 mol, 1.0 equiv) and K2CO3 (101.79 g, 0.74 mol, 2.3 equiv) in DMF (500 mL) was added BnBr (120.41 g, 0.70 mol, 2.2 equiv) at room temperature. The mixture was stirred overnight and filtered. The filtrate was diluted with water (1 L) and extracted with tert-butyl methyl ether (3 × 300 mL). The combined organic layers were washed with water (2 × 600 mL) and brine (1 × 600 mL), dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude product was mashed in hexane, filtered, washed with hexane, and dried. Yield: 97.44 g, 0.29 mol, 91%, white solid. 1H NMR (400 MHz, CDCl3) δ 7.41–7.28 (m, 10H), 5.15 (s, 4H), 2.39 (s, 6H) ppm. 13C{1H} NMR (101 MHz, CDCl3) δ 168.7, 135.6, 128.4, 128.1, 127.9, 77.2, 52.7, 37.6 ppm. HRMS (ESI-TOF) m/z: [M + H]+ calcd for C21H21O4 337.1440; found 337.1445.
3-((Benzyloxy)carbonyl)bicyclo[1.1.1]pentane-1-carboxylic Acid (19)
To a solution of 18 (25.0 g, 0.074 mol, 1.0 equiv) in dry THF (680 mL) was added LiOH·H2O (2.8 g, 0.067 mol, 0.9 equiv). The mixture was heated in an oil bath with a thermocouple at 50 °C for 72 h. The mixture was concentrated under reduced pressure. The residue was diluted with water (400 mL) and extracted with tert-butyl methyl ether (2 × 300 mL). The aqueous layer was acidified with 1 M HCl to pH ∼ 3. The precipitate was filtered, washed with distilled water (100 mL), and dissolved in EtOAc (400 mL). The solution was dried over Na2SO4, filtered, and concentrated under reduced pressure. Yield: 15.7 g, 0.0638 mol, 86%, white solid. 1H NMR (500 MHz, CDCl3) δ 11.65 (br s, 1H), 7.35 (s, 5H), 5.14 (s, 2H), 2.37 (s, 6H) ppm. 13C{1H} NMR (126 MHz, CDCl3) δ 174.8, 169.1, 135.5, 128.6, 128.3, 128.0, 77.2, 66.5, 52.8, 37.6, 37.5 ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd for C14H14NaO4 269.0790; found 269.0792.
1-Benzyl 3-(1,3-Dioxoisoindolin-2-yl) bicyclo[1.1.1]pentane-1,3-dicarboxylate (20)
To a solution of 19 (25.00 g, 0.100 mol, 1.0 equiv), N-hydroxyphthalimide (17.39 g, 0.107 mol, 1.05 equiv), and DMAP (1.22 g, 0.015 mol, 1.05 equiv) was added DIC (13.45 g, 0.107 mol, 1.05 equiv) dropwise at room temperature. The mixture was stirred overnight. The mixture was filtered, and the filtrate was concentrated under reduced pressure. The residue was dissolved in CH2Cl2 and washed with a sat. solution of Na2CO3 (3 × 200 mL) and 1 M HCl (3 × 200 mL). The organic layer was dried over Na2SO4, filtered, and concentrated under reduced pressure. Yield: 36.40 g, 0.039 mol, 93%, white solid. 1H NMR (500 MHz, CDCl3) δ 7.99–7.82 (m, 2H), 7.82–7.68 (m, 2H), 7.48–6.99 (m, 5H), 5.15 (s, 2H), 2.57 (s, 6H) ppm. 13C{1H} NMR (151 MHz, CDCl3) δ 168.3, 164.7, 161.7, 135.6, 134.9, 128.9, 128.7, 128.4, 128.1, 124.0, 77.2, 66.6, 53.7, 38.8, 35.5 ppm. HRMS (ESI-TOF) m/z: [M + H]+ calcd for C22H18NO6 392.1134; found 392.1130.
1-Benzyl 3-(1,3-Dioxoisoindolin-2-yl) bicyclo[1.1.1]pentane-1,3-dicarboxylate (21)
A solution of 20 (7.0 g, 0.0179 mol, 1.0 equiv) and 2,2′-bis(1,3,2-benzodioxaborole) (5.0 g, 0.021 mol, 1.2 equiv) in DMA (90 mL) was degassed with argon (5 times) then irradiated in flow. Irradiation: blue LED: 450 nm, radiation intensity: 15% of nominal, the temperature of the reaction mixture: 35 °C. After completion of the reaction, Et3N (5.4 g, 00537 mol, 3.0 equiv) and pinacol (3.1 g, 0.026 mol, 1.5 equiv) were added. The mixture was stirred at room temperature overnight. The mixture was extracted with a mixture of hexane:EtOAc, 9:1 (2 × 500 mL), and concentrated under reduced pressure. The residue was extracted with hexane (3 × 300 mL), and the combined layers were washed with water (2 × 300 mL) and brine (1 × 300 mL), dried over Na2SO4, filtered, and concentrated under reduced pressure. The excess of pinacol was removed by sublimation. Yield: 3.6 g, 0.011 mol, 61%, white solid. 1H NMR (500 MHz, CDCl3) δ 7.41–7.23 (m, 5H), 5.08 (s, 2H), 2.15 (s, 6H), 1.22 (s, 12H) ppm. 13C{1H} NMR (126 MHz, CDCl3) δ 169.5, 136.3, 128.6, 128.2, 128.0, 83.7, 65.9, 52.5, 43.1 ppm. HRMS (ESI-TOF) m/z: [M + H]+ calcd for C19H26BO4 329.1924; found 329.1918.
Potassium (3-((Benzyloxy)carbonyl)bicyclo[1.1.1]pentan-1-yl)trifluoroborate (22)
To a solution of 21 (10.0 g, 0.03 mol, 1.0 equiv) in a mixture of MeOH:H2O = 8:2 (100 mL) was added KF·HF (5.46 g, 0.07 mol, 2.5 equiv). The mixture was stirred at room temperature overnight and then concentrated. The final product was dried at 1 mmHg over P2O5 during 24 h. The product was mashed in MeOtBu (250 mL), and the precipitate was dissolved in acetone, decanted, and concentrated under reduced pressure. Yield: 7.30 g, 0.0237 mol, 79%, white solid. 1H NMR (500 MHz, DMSO-d6) δ 7.42–7.24 (m, 5H), 5.03 (s, 2H), 1.64 (s, 6H) ppm. 13C{1H} NMR (126 MHz, DMSO-d6) δ 169.9, 136.6, 128.5, 127.9, 127.7, 64.7, 50.5 ppm. 19F{1H} NMR (376 MHz, DMSO-d6) δ −143.0 (s) ppm. Anal. Calcd for C13H13BF3KO2: C, 50.67; H, 4.25. Found: C, 50.50; H, 4.35.
Benzyl 3-Hydroxybicyclo[1.1.1]pentane-1-carboxylate (23)
To a solution of KH2PO4 (15.92 g, 0.117 mol, 3.0 equiv) and compound 22 (12.00 g, 0.039 mol, 1.0 equiv) in a mixture of H2O (160 mL) and THF (240 mL) was added H2O2 (30%, 44.21 g, 0.390 mol, 10.0 equiv) dropwise at 0 °C. The mixture was stirred at room temperature overnight. The mixture was diluted with water (400 mL) and extracted with MeOtBu (2 × 300 mL). The combined organic layers were washed with water (1 × 500 mL) and a sat. solution of NaHSO3 (1 × 500 mL). The organic layer was dried over Na2SO4, filtered, and concentrated under reduced pressure. The residue was dissolved in a mixture of hexane:MeOtBu, 1:1 (60 mL), filtered through SiO2, and concentrated under reduced pressure. Yield: 3.0 g, 0.0137 mol, 35%, white solid. 1H NMR (400 MHz, CDCl3) δ 7.39–7.17 (m, 5H), 5.36 (s, 1H), 5.10 (s, 2H), 2.21 (s, 6H) ppm. 13C{1H} NMR (101 MHz, CDCl3) δ 170.4, 135.4, 128.3, 128.0, 127.7, 66.3, 61.8, 55.3, 30.3 ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd for C13H14NaO3 241.0841; found 241.0833.
3-Hydroxybicyclo[1.1.1]pentane-1-carboxylic Acid (14)
To a solution of compound 23 (3.0 g, 0.0137 mol, 1.0 equiv) in MeOH (50 mL) was added 10% Pd/C (0.25 g, 0.00234 mol, 0.1 equiv). The mixture was hydrogenated under a rubber ball filled with H2 at rt overnight. Pd/C was filtered out, and the reaction mixture was concentrated under reduced pressure. Yield: 1.3 g, 0.01 mol, 74%, white solid. Mp = 98–99 °C. 1H NMR (400 MHz, DMSO-d6) δ 12.25 (br s, 1H), 6.40 (br s, 1H), 1.98 (s, 6H) ppm. 13C{1H} NMR (126 MHz, DMSO-d6) δ 171.5, 61.7, 54.9, 30.6 ppm. HRMS (ESI-TOF) m/z: [M + H]+ calcd for C6H9O3 129.0552; found 129.0543.
Acknowledgments
The authors are grateful to Mrs. I. Sadkova for the help with the preparation of the manuscript and to Mr. I. Stadniy and Mr. M. Kucherbaev for the technical assistance with photoreactors. This project has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (grant agreement No. 101000893 - BENOVELTY).
Supporting Information Available
The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.joc.1c00977.
Copies of NMR spectra (PDF)
The authors declare no competing financial interest.
Supplementary Material
References
- Taylor R. D.; MacCoss M.; Lawson A. D. G. Rings in Drugs. J. Med. Chem. 2014, 57, 5845–5859. 10.1021/jm4017625. [DOI] [PubMed] [Google Scholar]
- The search can be performed at www.drugbank.ca.
- Ritchie T. J.; Macdonald S. J. F. The impact of aromatic ring count on compound developability – are too many aromatic rings a liability in drug design?. Drug Discovery Today 2009, 14, 1011–1020. 10.1016/j.drudis.2009.07.014. [DOI] [PubMed] [Google Scholar]
- Stepan A. F.; Mascitti V.; Beaumont K.; Kalgutkar A. S. Metabolism-guided drug design. MedChemComm 2013, 4, 631–652. 10.1039/c2md20317k. [DOI] [Google Scholar]
- a Lovering F.; Bikker J.; Humblet C. Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success. J. Med. Chem. 2009, 52, 6752–6756. 10.1021/jm901241e. [DOI] [PubMed] [Google Scholar]; b Lovering F. Escape from Flatland 2: complexity and promiscuity. MedChemComm 2013, 4, 515–519. 10.1039/c2md20347b. [DOI] [Google Scholar]
- For reviews on the use of bicyclo[1.1.1]pentanes and related structures as saturated bioisosteres of benzene in medicinal chemistry, see:; a Mykhailiuk P. K. Saturated bioisosteres of benzene: where to go next?. Org. Biomol. Chem. 2019, 17, 2839–2849. 10.1039/C8OB02812E. [DOI] [PubMed] [Google Scholar]; b Locke G. M.; Bernhard S. S. R.; Senge M. O. Nonconjugated Hydrocarbons as Rigid-Linear Motifs: Isosteres for Material Sciences and Bioorganic and Medicinal Chemistry. Chem. - Eur. J. 2019, 25, 4590–4647. 10.1002/chem.201804225. [DOI] [PubMed] [Google Scholar]
- Stepan A. F.; Subramanyam C.; Efremov I. V.; Dutra J. K.; O’Sullivan T. J.; DiRico K. J.; McDonald W. S.; Won A.; Dorff P. H.; Nolan C. E.; Becker S. L.; Pustilnik L. R.; Riddell D. R.; Kauffman G. W.; Kormos B. L.; Zhang L.; Lu Y.; Capetta S. H.; Green M. E.; Karki K.; Sibley E.; Atchison K. P.; Hallgren A. J.; Oborski C. E.; Robshaw A. E.; Sneed B.; O’Donnell C. J. Application of the Bicyclo[1.1.1]pentane Motif as a Nonclassical Phenyl Ring Bioisostere in the Design of a Potent and Orally Active γ-Secretase Inhibitor. J. Med. Chem. 2012, 55, 3414–3424. 10.1021/jm300094u. [DOI] [PubMed] [Google Scholar]
- For some recent examples of application of bicyclo[1.1.1]pentanes in medicinal chemistry:; a Pu Q.; Zhang H.; Guo L.; Cheng M.; Doty A. C.; Ferguson H.; Fradera X.; Lesburg C. A.; McGowan M. A.; Miller J. R.; Geda P.; Song X.; Otte K.; Sciammetta N.; Solban N.; Yu W.; Sloman D. L.; Zhou H.; Lammens A.; Neumann L.; Bennett D. J.; Pasternak A.; Han Y. Discovery of Potent and Orally Available Bicyclo[1.1.1]pentane derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors. ACS Med. Chem. Lett. 2020, 11, 1548–1554. 10.1021/acsmedchemlett.0c00195. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Measom N. D.; Down K. D.; Hirst D. J.; Jamieson C.; Manas E. S.; Patel V. K.; Somers D. O. Investigation of a Bicyclo[1.1.1]pentane as a Phenyl Replacement within an LpPLA2 Inhibitor. ACS Med. Chem. Lett. 2017, 8, 43–48. 10.1021/acsmedchemlett.6b00281. [DOI] [PMC free article] [PubMed] [Google Scholar]
- For some recent examples, see:; a Gianatassio R.; Lopchuk J. M.; Wang J.; Pan C.-M.; Malins L. R.; Prieto L.; Brandt T. A.; Collins M. R.; Gallego G. M.; Sach N. W.; Spangler J. E.; Zhu H.; Zhu J.; Baran P. S. Strain-release amination. Science 2016, 351, 241–246. 10.1126/science.aad6252. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Kanazawa J.; Maeda K.; Uchiyama M. Radical Multicomponent Carboamination of [1.1.1]Propellane. J. Am. Chem. Soc. 2017, 139, 17791–17794. 10.1021/jacs.7b11865. [DOI] [PubMed] [Google Scholar]; c Caputo D. F. J.; Arroniz C.; Dürr A. B.; Mousseau J. J.; Stepan A. F.; Mansfield S. J.; Anderson E. A. Synthesis and applications of highly functionalized 1-halo-3-substituted bicyclo[1.1.1]pentanes. Chem. Sci. 2018, 9, 5295–5390. 10.1039/C8SC01355A. [DOI] [PMC free article] [PubMed] [Google Scholar]; d Shelp R. A.; Walsh P. J. Synthesis of BCP Benzylamines from 2-Azaallyl Anions and [1.1.1]Propellane. Angew. Chem., Int. Ed. 2018, 57, 15857–15861. 10.1002/anie.201810061. [DOI] [PubMed] [Google Scholar]; e Makarov I. S.; Brocklehurst C. E.; Karaghiosoff K.; Koch G.; Knochel P. Synthesis of Bicyclo[1.1.1]pentane Bioisosteres of Internal Alkynes and para-Disubstituted Benzenes from [1.1.1]Propellane. Angew. Chem., Int. Ed. 2017, 56, 12774–12777. 10.1002/anie.201706799. [DOI] [PubMed] [Google Scholar]; f Lopchuk J. M.; Fjelbye K.; Kawamata Y.; Malins L. R.; Pan C.-M.; Gianatassio R.; Wang J.; Prieto L.; Bradow J.; Brandt T. A.; Collins M. R.; Elleraas J.; Ewanicki J.; Farrell W.; Fadeyi O. O.; Gallego G. M.; Mousseau J. J.; Oliver R.; Sach N. W.; Smith J. K.; Spangler J. E.; Zhu H.; Zhu J.; Baran P. S. Strain-release heteroatom functionalization: development, scope, and stereospecificity. Strain-Release Heteroatom Functionalization: Development, Scope, and Stereospecificity. J. Am. Chem. Soc. 2017, 139, 3209–3226. 10.1021/jacs.6b13229. [DOI] [PMC free article] [PubMed] [Google Scholar]; g Wong M. L. J.; Mousseau J. J.; Mansfield S. J.; Anderson E. A. Synthesis of enantioenriched α-chiral bicyclo[1.1.1]pentanes. Org. Lett. 2019, 21, 2408–2411. 10.1021/acs.orglett.9b00691. [DOI] [PubMed] [Google Scholar]; h Zarate C.; Ardolino M.; Morriello G. J.; Logan K. M.; Kaplan W. P.; Torres L.; Li D.; Chen M.; Li H.; Su J.; Fuller P.; Maddess M. L.; Song Z. J. Development of Scalable Routes to 1-Bicyclo[1.1.1]pentylpyrazoles. Org. Process Res. Dev. 2021, 25, 642–647. 10.1021/acs.oprd.0c00446. [DOI] [Google Scholar]; i Nugent J.; Shire B. R.; Caputo D. F. J.; Pickford H. D.; Nightingale F.; Houlsby I. T. T.; Mousseau J. J.; Anderson E. A. Synthesis of All-Carbon Disubstituted Bicyclo[1.1.1]pentanes by Iron-Catalyzed Kumada Cross-Coupling. Angew. Chem., Int. Ed. 2020, 59, 11866–11870. 10.1002/anie.202004090. [DOI] [PMC free article] [PubMed] [Google Scholar]; j Zhang X.; Smith R. T.; Le C.; McCarver S. J.; Shireman B. T.; Carruthers N. I.; MacMillan D. W. C. Copper-mediated synthesis of drug-like bicyclopentanes. Nature 2020, 580, 220–226. 10.1038/s41586-020-2060-z. [DOI] [PMC free article] [PubMed] [Google Scholar]; k Garlets Z. J.; Sanders J. N.; Malik H.; Gampe C.; Houk K. N.; Davies H. M. L. Enantioselective C–H functionalization of bicyclo[1.1.1]pentanes. Nature Catalysis 2020, 3, 351–357. 10.1038/s41929-019-0417-1. [DOI] [Google Scholar]; l Ma X.; Han Y.; Bennett D. J. Org. Lett. 2020, 22, 9133–9138. 10.1021/acs.orglett.0c03612. [DOI] [PubMed] [Google Scholar]; m Hughes J. M. E.; Scarlata D. A.; Chen A. C.-Y.; Burch J. D.; Gleason J. L. Aminoalkylation of [1.1.1]Propellane Enables Direct Access to High-Value 3-Alkylbicyclo[1.1.1]pentan-1-amines. Org. Lett. 2019, 21, 6800–6804. 10.1021/acs.orglett.9b02426. [DOI] [PubMed] [Google Scholar]; n Shelp R. A.; Ciro A.; Pu Y.; Merchant R. R.; Hughes J. M. E.; Walsh P. J. Strain-Release 2-Azaallyl Anion Addition/Borylation of [1.1.1]Propellane: Synthesis and Functionalization of Benzylamine Bicyclo[1.1.1]pentyl Boronates. Chem. Sci. 2021, 12, 7066–7072. 10.1039/D1SC01349A. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Our contribution to the field:; a Kokhan S. O.; Tymtsunik A. V.; Grage S. L.; Afonin S.; Babii O.; Berditsch M.; Strizhak A. V.; Bandak D.; Platonov M. O.; Komarov I. V.; Ulrich A. S.; Mykhailiuk P. K. Design, Synthesis, and Application of an Optimized Monofluorinated Aliphatic Label for Peptide Studies by Solid-State 19F NMR Spectroscopy. Angew. Chem., Int. Ed. 2016, 55, 14788–14792. 10.1002/anie.201608116. [DOI] [PubMed] [Google Scholar]; b Mykhailiuk P. K.; Voievoda N. M.; Afonin S.; Ulrich A. S.; Komarov I. V. An optimized protocol for the multigram synthesis of 3-(trifluoromethyl)bicyclo[1.1.1]pent-1-ylglycine (CF3-Bpg). J. Fluorine Chem. 2010, 131, 217–220. 10.1016/j.jfluchem.2009.10.004. [DOI] [Google Scholar]; c Mikhailiuk P. K.; Afonin S.; Chernega A. N.; Rusanov E. B.; Platonov M. O.; Dubinina G. G.; Berditsch M.; Ulrich A. S.; Komarov I. V. Conformationally Rigid Trifluoromethyl-Substituted α-Amino Acid Designed for Peptide Structure Analysis by Solid-State 19F NMR Spectroscopy. Angew. Chem., Int. Ed. 2006, 45, 5659–5661. 10.1002/anie.200600346. [DOI] [PubMed] [Google Scholar]; d Bychek R. M.; Hutskalova V.; Bas Y. P.; Zaporozhets O. A.; Zozulya S.; Levterov V. V.; Mykhailiuk P. K. Difluoro-Substituted Bicyclo[1.1.1]pentanes for Medicinal Chemistry: Design, Synthesis, and Characterization. J. Org. Chem. 2019, 84, 15106–15117. 10.1021/acs.joc.9b01947. [DOI] [PubMed] [Google Scholar]; e Levterov V. V.; Panasyuk Y.; Pivnytska V. O.; Mykhailiuk P. K. Water-Soluble Non-Classical Benzene Mimetics. Angew. Chem., Int. Ed. 2020, 59, 7161–7167. 10.1002/anie.202000548. [DOI] [PubMed] [Google Scholar]; f Denisenko A.; Garbuz P.; Shishkina S.; Voloshchuk N. M.; Mykhailiuk P. Saturated Bioisosteres of ortho-Substituted Benzenes. Angew. Chem., Int. Ed. 2020, 59, 20515–20521. 10.1002/anie.202004183. [DOI] [PubMed] [Google Scholar]
- For recent reviews on the synthesis of bicyclo[1.1.1]pentanes, see:; a Kanazawa J.; Uchiyama M. Recent Advances in the Synthetic Chemistry of Bicyclo[1.1.1]pentane. Synlett 2019, 30, 1–11. 10.1055/s-0037-1610314. [DOI] [Google Scholar]; b Ma X.; Pham L. N. Selected Topics in the Syntheses of Bicyclo[1.1.1]Pentane (BCP) Analogues. Asian J. Org. Chem. 2020, 9, 8–22. 10.1002/ajoc.201900589. [DOI] [Google Scholar]; c He F.-S.; Xie S.; Yao Y.; Wu J. Recent advances in the applications of [1.1.1]-propellane in organic synthesis. Chin. Chem. Lett. 2020, 31, 3065–3072. 10.1016/j.cclet.2020.04.023. [DOI] [Google Scholar]
- Applequist D. E.; Renken T. L.; Wheeler J. W. Polar Substituent Effects in 1,3-Disubstituted Bicyclo[1.1.1]Pentanes. J. Org. Chem. 1982, 47, 4985–4995. 10.1021/jo00146a031. [DOI] [Google Scholar]
- Hall H. K.; Smith C. D.; Blanchard E. P.; Cherkofsky S. C.; Sieja J. B. Bridgehead Substituents Polimersiation. J. Am. Chem. Soc. 1971, 93, 121–130. 10.1021/ja00730a022. [DOI] [Google Scholar]
- Kaszynski P.; Michl J. A practical photochemical synthesis of bicyclo[1.1.1]pentane-1,3-dicarboxylic acid. J. Org. Chem. 1988, 53, 4593–4594. 10.1021/jo00254a038. [DOI] [Google Scholar]
- Levin M. D.; Kaszynski P.; Michl J. Photochemical synthesis of bicyclo[1.1.1]pentane-1,3-dicarboxylic acid. Org. Synth. 2000, 77, 249. 10.1002/0471264180.os077.27. [DOI] [Google Scholar]
- Elliott L. D.; Knowles J. P.; Koovits P. J.; Maskill K. G.; Ralph M. J.; Lejeune G.; Edwards L. J.; Robinson R. I.; Clemens I. R.; Cox B.; Pascoe D. D.; Koch G.; Eberle M.; Berry M. B.; Booker-Milburn K. I. Batch versus Flow Photochemistry: A Revealing Comparison of Yield and Productivity. Chem. - Eur. J. 2014, 20, 15226–15232. 10.1002/chem.201404347. [DOI] [PubMed] [Google Scholar]
- Baumann M.; Donnelly K. A Continuous Flow Synthesis of [1.1.1]Propellane and Bicyclo[1.1.1]Pentane Derivatives. Chem. Commun. 2021, 57, 2871–2874. 10.1039/D0CC08124H. [DOI] [PubMed] [Google Scholar]
- Previously, this transformation was described in a patent:Suzuki Y.; Jimenez-Teja D.; Salomé C.; Fessard T.. Method of Preparing Substituted Bicyclo[1.1.1]pentanes. WO 2017157932 A1, 2017.
- Wiberg K. B.; Walker F. H. [1.1.1]Prope1lane. J. Am. Chem. Soc. 1982, 104, 5239–5240. 10.1021/ja00383a046. [DOI] [Google Scholar]
- Semmler K.; Szeimies G.; Belzner J. Tetracyclo[5.1.0.01,6.02,7]Octane, a [1.1.1]Propellane Derivative, and a New Route to the Parent Hydrocarbon. J. Am. Chem. Soc. 1985, 107, 6410–6411. 10.1021/ja00308a053. [DOI] [Google Scholar]
- Mondanaro K. R.; Dailey W. P. [1.1.1]Propellane. Org. Synth. 1998, 75, 98. 10.15227/orgsyn.075.0098. [DOI] [Google Scholar]
- Wiberg K. B.; Waddell S. T. Reactions of [1.1.1]Propellane. J. Am. Chem. Soc. 1990, 112, 2194–2216. 10.1021/ja00162a022. [DOI] [Google Scholar]
- In recent years, we became involved in photochemical [2 + 2]-cycloadditions under irradiation at 365 nm using benzophenone as a triplet sensitizer:; a Mykhailiuk P. K.; Kubyshkin V.; Bach T.; Budisa N. Peptidyl-prolyl model study: how does the electronic effect influence the amide bond conformation?. J. Org. Chem. 2017, 82, 8831–8841. 10.1021/acs.joc.7b00803. [DOI] [PubMed] [Google Scholar]; b Denisenko A. V.; Druzhenko T.; Skalenko Y.; Samoilenko M.; Grygorenko O. O.; Zozulya S.; Mykhailiuk P. K. Photochemical Synthesis of 3-Azabicyclo[3.2.0]Heptanes: Advanced Building Blocks for Drug Discovery. J. Org. Chem. 2017, 82, 9627–9636. 10.1021/acs.joc.7b01678. [DOI] [PubMed] [Google Scholar]; c Levterov V. V.; Michurin O.; Borysko P. O.; Zozulya S.; Sadkova I. V.; Tolmachev A. A.; Mykhailiuk P. K. Photochemical in-flow synthesis of 2,4-methanopyrrolidines: pyrrolidine analogues with improved water solubility and reduced lipophilicity. J. Org. Chem. 2018, 83, 14350–14361. 10.1021/acs.joc.8b02071. [DOI] [PubMed] [Google Scholar]; d Skalenko Y. A.; Druzhenko T. V.; Denisenko A. V.; Samoilenko M. V.; Dacenko O. P.; Trofymchuk S. A.; Grygorenko O. O.; Tolmachev A. A.; Mykhailiuk P. K. [2 + 2]-Photocycloaddition of N-benzylmaleimide to alkenes as an approach to functional 3-azabicyclo[3.2.0]heptanes. J. Org. Chem. 2018, 83, 6275–6289. 10.1021/acs.joc.8b00077. [DOI] [PubMed] [Google Scholar]; e Druzhenko T.; Skalenko Y.; Samoilenko M.; Denisenko A.; Zozulya S.; Borysko P. O.; Sokolenko M. I.; Tarasov A.; Mykhailiuk P. K. Photochemical synthesis of 2-azabicyclo[3.2.0]heptanes: advanced building blocks for drug discovery. Synthesis of 2,3-ethanoproline. J. Org. Chem. 2018, 83, 1394–1401. 10.1021/acs.joc.7b02910. [DOI] [PubMed] [Google Scholar]; f Shcherbakova V.; Dibchak D.; Snisarenko M.; Skalenko Y.; Denisenko A. V.; Kuznetsova A. S.; Mykhailiuk P. K. Bicyclic Piperidines via [2 + 2] Photocycloaddition. J. Org. Chem. 2021, 86, 2200–2209. 10.1021/acs.joc.0c02355. [DOI] [PubMed] [Google Scholar]
- https://download.luminus.com/datasheets/Luminus_SST-10-UV_Datasheet.pdf.
- https://www.altaflo.com/products/fep-altafluor-200/.
- Goh Y. L.; Adsool V. A. Radical fluorination powered expedient synthesis of 3-fluorobicyclo[1.1.1]pentan-1-amine. Org. Biomol. Chem. 2015, 13, 11597–11601. 10.1039/C5OB02066B. [DOI] [PubMed] [Google Scholar]
- Pätzel M.; Sanktjohanser M.; Doss A.; Henklein P.; Szeimies G. 3-Aminobicyclo[1.1.1]pentane-1-carboxylic Acid Derivatives: Synthesis and Incorporation into Peptides. Eur. J. Org. Chem. 2004, 2004, 493–498. 10.1002/ejoc.200300554. [DOI] [Google Scholar]
- Fawcett A.; Pradeilles J.; Wang Y.; Mutsuga T.; Myers E. L.; Aggarwal V. K. Photoinduced decarboxylative borylation of carboxylic acids. Science 2017, 357, 283–286. 10.1126/science.aan3679. [DOI] [PubMed] [Google Scholar]
- VanHeyst M. D.; Qi J.; Roecker A. J.; Hughes J. M. E.; Cheng L.; Zhao Z.; Yin J. Continuous Flow-Enabled Synthesis of Bench-Stable Bicyclo[1.1.1]pentane Trifluoroborate Salts and Their Utilization in Metallaphotoredox Cross-Couplings. Org. Lett. 2020, 22, 1648–1654. 10.1021/acs.orglett.0c00242. [DOI] [PubMed] [Google Scholar]
- Xiang J.; Shang M.; Kawamata Y.; Lundberg H.; Reisberg S. H.; Chen M.; Mykhailiuk P.; Beutner G.; Collins M. R.; Davies A.; Del Bel M.; Gallego G. M.; Spangler J. E.; Starr J.; Yang S.; Blackmond D. G.; Baran P. S. Hindered Dialkyl Ether Synthesis with Electrogenerated Carbocations. Nature 2019, 573, 398–402. 10.1038/s41586-019-1539-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Goh Y. L.; Cui Y. T.; Pendharkar V.; Adsool V. A. Toward Resolving the Resveratrol Conundrum: Synthesis and in Vivo Pharmacokinetic Evaluation of BCP–Resveratrol. ACS Med. Chem. Lett. 2017, 8, 516–520. 10.1021/acsmedchemlett.7b00018. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.




